Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease
- 25 January 2008
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 23 (1), 21-27
- https://doi.org/10.1002/mds.21701
Abstract
Myocardial 123Metaiodobenzylguanidine (MIBG) enables the assessment of postganglionic sympathetic cardiac innervation. MIBG uptake is decreased in nearly all patients with Parkinson's disease (PD). Our objective was to evaluate MIBG uptake in patients with genetic PD. We investigated MIBG uptake in 14 patients with PD associated with mutations in different genes (Parkin, DJ‐1, PINK1, and leucine‐rich repeat kinase 2 ‐LRRK2), in 15 patients with idiopathic PD, and 10 control subjects. The myocardial MIGB uptake was preserved in 3 of the 4 Parkin‐associated Parkinsonisms, in 1 of the 2 patients with DJ‐1 mutations, in 1 of the 2 brothers with PINK1 mutations, in 3 of the 6 unrelated patients with Gly2019Ser mutation in the LRRK2 gene, whereas it was impaired in all patients with idiopathic PD. MIBG was preserved in all control subjects. Our study shows that myocardial MIGB uptake was normal in 8 of 14 patients with genetic PD, suggesting that cardiac sympathetic denervation occurs less frequently in genetic PD than in idiopathic PD. Our findings also demonstrate that MIGB uptake has a heterogeneous pattern in genetic PD, because it was differently impaired in patients with different mutations in the same gene or with the same gene mutation. © 2007 Movement Disorder SocietyKeywords
This publication has 26 references indexed in Scilit:
- Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2Movement Disorders, 2005
- Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: First case reportMovement Disorders, 2005
- Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2005
- FP‐CIT and MIBG scintigraphy in early Parkinson's diseaseMovement Disorders, 2005
- Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's diseaseMovement Disorders, 2003
- Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSANeurology, 2001
- Cardiac uptake of [ 123 I]MIBG separates Parkinson’s disease from multiple system atrophyNeurology, 1999
- 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failureActa Neurologica Scandinavica, 1998
- Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinsonʼs diseaseNuclear Medicine Communications, 1998